HDAC7 and breast cancer: [133] showed that a class IIa HDAC inhibitor enhanced macrophage‐mediated anti‐tumour responses in a mouse breast cancer model, suggesting that HDAC7 and/or other class IIa HDACs may dampen tumoricidal activity of macrophages.